Yaron Weber
Stock Analyst at TD Cowen
(2.35)
# 2,626
Out of 5,238 analysts
9
Total ratings
55.56%
Success rate
12.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Weber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Reiterates: Buy | $325 | $238.66 | +36.18% | 1 | Jan 7, 2026 | |
| ZYME Zymeworks | Initiates: Buy | n/a | $23.89 | - | 1 | May 20, 2025 | |
| AMGN Amgen | Maintains: Buy | $381 → $383 | $331.70 | +15.47% | 5 | Oct 21, 2024 | |
| NUVB Nuvation Bio | Initiates: Outperform | n/a | $4.79 | - | 1 | Mar 8, 2021 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $684 → $565 | $714.89 | -20.97% | 1 | Feb 8, 2021 |
Ascendis Pharma
Jan 7, 2026
Reiterates: Buy
Price Target: $325
Current: $238.66
Upside: +36.18%
Zymeworks
May 20, 2025
Initiates: Buy
Price Target: n/a
Current: $23.89
Upside: -
Amgen
Oct 21, 2024
Maintains: Buy
Price Target: $381 → $383
Current: $331.70
Upside: +15.47%
Nuvation Bio
Mar 8, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.79
Upside: -
Regeneron Pharmaceuticals
Feb 8, 2021
Maintains: Outperform
Price Target: $684 → $565
Current: $714.89
Upside: -20.97%